AG
EXAS

Advisor Group’s Exact Sciences EXAS Stock Holding History

Advisor Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$12.6M Buy
136,567
+57,257
+72% +$5.03M 0.09% 199
2019
Q3 		$7.17M Buy
79,310
+13,557
+21% +$1.54M 0.05% 308
2019
Q2 		$7.76M Sell
65,753
-6,718
-9% -$677K 0.06% 278
2019
Q1 		$6.28M Buy
72,471
+20,513
+39% +$1.75M 0.05% 312
2018
Q4 		$3.28M Buy
51,958
+31,573
+155% +$2.17M 0.03% 437
2018
Q3 		$1.61M Buy
20,385
+2,194
+12% +$143K 0.02% 738
2018
Q2 		$1.09M Sell
18,191
-769
-4% -$41.4K 0.02% 820
2018
Q1 		$764K Buy
18,960
+5,962
+46% +$291K 0.01% 1034
2017
Q4 		$683K Buy
12,998
+929
+8% +$49.6K 0.01% 1123
2017
Q3 		$570K Buy
12,069
+4,203
+53% +$169K 0.01% 1117
2017
Q2 		$279K Buy
7,866
+65
+0.8% +$2.01K ﹤0.01% 1530
2017
Q1 		$184K Buy
7,801
+6,066
+350% +$120K ﹤0.01% 1729
2016
Q4 		$24K Buy
1,735
+1,350
+351% +$21.8K ﹤0.01% 3107
2016
Q3 		$7K Buy
+385
New +$6.78K ﹤0.01% 3749

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Advisor Group's EXAS Position: Q4 2019 in Review

Advisor Group increased its Exact Sciences (EXAS) stake by 72% in Q4 2019, buying an estimated $5.03M and bringing the position to 136,567 shares worth $12.6M. The position accounts for 0.09% of the portfolio, ranked #199.

Advisor Group first reported a position in EXAS in Q3 2016 and has held it in 14 quarters since. 526 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Advisor Group held 136,567 shares of Exact Sciences worth $12.6M as of Q4 2019.
  • Advisor Group bought 57,257 Exact Sciences shares in Q4 2019, an estimated $5.03M.
  • Exact Sciences made up 0.09% of Advisor Group's portfolio in Q4 2019, its #199 holding.
  • Advisor Group first reported a position in Exact Sciences in Q3 2016 and has held it in 14 quarters since.
  • 526 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.